A study to look at the effect MEDI0382 has on blood sugar in people with type 2 diabetes and kidney problems and also to check that MEDI0382 is well tolerated

Trial Identifier: D5670C00013
Sponsor: MedImmune, LLC
NCTID:: NCT03550378
Start Date: June 2018
Primary Completion Date: February 2019
Condition: Kidney Diseases; Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 10117
Germany Dusseldorf, Germany, 40210
Germany Magdeburg, Germany, 39120
Germany München, Germany, 81241
Germany Munster, Germany, 48145
United Kingdom Airdrie, United Kingdom, ML6 0JS
United Kingdom Dundee, United Kingdom, DD1 9SY
United Kingdom Edinburgh, United Kingdom, EH16 4SA
United Kingdom Edinburgh, United Kingdom, EH4 2XU
United Kingdom Glasgow, United Kingdom, G75 8RG
United Kingdom Kirkaldy, United Kingdom, KY2 5AH